Cancers, Vol. 16, Pages 808: Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the D & uuml;sseldorf MDS Registry
Cancers, Vol. 16, Pages 808: Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry
Cancers doi: 10.3390/cancers16040808
Authors:
Annika Kasprzak
Julia Andresen
Kathrin Nachtkamp
Andrea Kündgen
Felicitas Schulz
Corinna Strupp
Guido Kobbe
Colin MacKenzie
Jörg Timm
Sascha Dietrich
Norbert Gattermann
Ulrich Germing
Despite notable advancements in infection prevention and treatment, individuals with hematologic malignancies still face the persistent threat of frequent and life-threatening complications. Those undergoing chemotherapy or other disease-modifying therapies are particularly vulnerable to developing infectious complications, increasing the risk of mortality. Myelodysplastic syndromes (MDS) predominantly affect the elderly, with the incidence rising with age and peaking at around 70 years. Patients with MDS commonly present with unexplained low blood-cell counts, primarily anemia, and often experience varying degrees of neutropenia as the disease progresses. In our subsequent retrospective study involving 1593 patients from the Düsseldorf MDS Registry, we aimed at outlining the incidence of infections in MDS patients and identifying factors contributing to heightened susceptibility to infectious complications in this population.
Source: Cancers - Category: Cancer & Oncology Authors: Annika Kasprzak Julia Andresen Kathrin Nachtkamp Andrea K ündgen Felicitas Schulz Corinna Strupp Guido Kobbe Colin MacKenzie J örg Timm Sascha Dietrich Norbert Gattermann Ulrich Germing Tags: Article Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Myelodysplastic Syndrome | Nutrition | Study